Skip to main content
OpenTrials
Completed

NCT Number: NCT00414479

Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of Treatment

The purpose of this study is to determine the extend and the nature of anemia in school children and the correlation between anemia and schistosomiasis infections, malaria infections and/or malnutrition (iron deficiency).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anaemia Anemia Helminthiasis Hematologic Diseases Hemic and Lymphatic Diseases Infections Iron Deficiencies Iron Deficiency Iron Metabolism Disorders Malaria Metabolic Diseases Mosquito-Borne Diseases Nutritional and Metabolic Diseases Parasitic Diseases Protozoan Infections Schistosomiasis Schistosomiasis Infection Trematode Infections Vector Borne Diseases

Age range

9 year–12 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kenya Medical Research Institute

Kisumu, Kenya

About this study

The study will be carried out in an area around Lake Victoria in Kenya where the prevalence of schistosomiasis and malaria are highest in the areas nearest to the Lake. Depending on the prevalence of schistosomiasis a sample of between 876 to 2.524 children will be enrolled in the study. The children who will be in the age between 9 to 12 year, will have their stool and urine examined for schistosomiasis and intestinal worms and a blood sample will be examined for malaria parasites and the hemoglobin level. Children will also be weight, measured and examined by a doctor and register their food intake over one week, to determine their nutritional status. Children who are found to be infected with schistosomiasis, intestinal worms or malaria will be offered treatment. Children who are found to have anemia will be offered a course of iron supplementation, children with severe anemia will be referred to the nearest health facility for treatment. 12 months after the initial examinations and treatment all children will have a re-examination of their stool, urine and blood.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • school children between 9 to 12 year

Treatment and study plan

praziquantl, iron, ACT

Drug

Primary outcomes

  1. hemoglobin level

Secondary outcomes

  1. Schistosomiasis infection

  2. malaria infection

  3. iron deficiency

Sponsors and collaborators

Lead sponsor

DBL -Institute for Health Research and Development

Other

Registry information

Important dates

Study start
2006
Primary completion
2010
Study completion
2010
First posted
Dec 21, 2006
Registry last updated
Jan 14, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.